WASHINGTON, Aug. 29 -- Law firms assisted companies in the following recently announced transactions: * * * Goodwin... ...advised the biotechnology company Freenome on an exclusive licensing agreement with Exact Sciences. The purpose of this $885 million agreement is to commercialize Freenome's blood-based screening test for colorectal cancer, granting Exact Sciences U.S. commercial rights and the underlying technology. The terms of the deal include an upfront payment, milestone payments, roy more ST